Bios Equity Partners II, LP
SEC CIK 1813313 · EDGAR
BoughtSold
Most active insiders at CGTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Doyle John Brendan | CFO | $11.3K | — |
| 2 | Caggiano Anthony | Chief Medical Off | $11.1K | — |
| 3 | Ricciardi Lisa | CEO, Pres, Dir | $10.1K | — |
| 4 | Wallace Peggy | Dir | — | — |
| 5 | Fletcher Aaron G.L. | Dir, 10% | — | — |
| 6 | Khattar Jack A. | Dir | — | — |
| 7 | Monia Brett P | Dir | — | — |
| 8 | RICHSTONE ELLEN B | Dir | — | — |
Bios Equity Partners II, LP made no open-market trades at CGTX in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-11 | 2024-06-07 | CGTX | COGNITION THERAPEUTICS INC | Bios Equity Partners II, LP | Dir, 10% | A - Grant | $0.00 | +8,500 | 14.5K | +142% | $0 |
| MI | 2024-02-29 | 2024-02-27+ | LTRN | Lantern Pharma Inc. | Bios Equity Partners II, LP | 10% | S - Sale | $4.70 | -144.0K | 515.4K | -22% | -$676.3K |
| MI | 2022-09-29 | 2022-09-28 | INAB | IN8BIO, INC. | Bios Equity Partners II, LP | Dir, 10% | P - Purchase | $2.02 | +25.0K | 562.0K | +5% | +$50.5K |
Purchase Sale Sale after option exercise All abbreviations